This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Covington D, Gooden K, McKain L.Advancing the Field of Drug Safety in Pregnancy: A Decade of Abstracts Presented at ICPE. AAP Capital Letters: abstr. 106, 14 Aug 2011. Available from: URL: http://www.pharmacoepi.org
Covington D, Gooden K, McKain L.Medications in Pregnancy Special Interest Group: Improving the Quality of Science and Expanding Knowledge. AAP Capital Letters: abstr. 169, 14 Aug 2011. Available from: URL: http://www.pharmacoepi.org
Beppu H, Kokan A, Kubota K, Nakamura T, Orii T, Sato T, Task KT.Health Professionals Ask for Unifying Risk Minimization Programs on Teratogenic Agents. AAP Capital Letters: abstr. 139, 14 Aug 2011. Available from: URL: http://www.pharmacoepi.org
Peters SL, Humphrey JR, Broussard CS.Environmental Scan of Safe Medications during Pregnancy Lists. AAP Capital Letters: abstr. 133, 14 Aug 2011. Available from: URL: http://www.pharmacoepi.org
Seddoh SA, Guo JJ, Ajayi FO, Wigle PR.Adverse Events of Promethazine and Ondansetron in Young Children and Women of Child-Bearing Age: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System. AAP Capital Letters: abstr. 115, 14 Aug 2011. Available from: URL: http://www.pharmacoepi.org
Rights and permissions
About this article
Cite this article
Safety of drugs in pregnancy big news at ICPE. React. Wkly. 1373, 3–4 (2011). https://doi.org/10.2165/00128415-201113730-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201113730-00006